secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0000064803-26-000051
Event type: earnings
Sentiment:  positive
Materiality: 0.78
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Q1 revenue $100.4B (+6.2% YoY); raises FY26 EPS guidance to $7.30-7.50
--------------------------------------------------------------------------

- GAAP diluted EPS $2.30 vs $1.41 YoY; Adjusted EPS $2.57 vs $2.25 YoY.
- Health Care Benefits MBR improved to 84.6% (down 270 bps); adjusted op income up 52.6% to $3.04B.
- Health Services segment revenue $48.2B (+11.0%) but adj op income -7.1% on client price improvements.
- Pharmacy & Consumer Wellness adj op income -8.8% due to reimbursement pressure and seasonal illness decline.
- FY26 guidance raised: GAAP EPS $6.24-6.44 (from $5.94-6.14); cash from ops at least $9.5B (from $9.0B).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480326000051/0000064803-26-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480326000051/cvs-20260506.htm
  HTML page:      https://secwatch.observer/filing/0000064803-26-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer